Cancer News

Odronextamab: breakthrough for RR follicular lymphoma? Phase II ELM-2

Apr 4, 2023 2:12:23 PM / by Tae Min Kim, MD, PhD posted in ASH, Follicular Lymphoma, Odronextamab

0 Comments

Odronextamab: Promising Results in Treating Relapsed/Refractory Follicular Lymphoma: Findings from Phase II Study ELM-2 Tae Min Kim MD - Synopsis below extracted from the video transcript.

 

Read More

Subscribe to Email Updates

Recent Posts